Thomas Englese

Thomas Englese

Corporate Officer/Principal bij TONIX PHARMACEUTICALS HOLDING CORP.

Vermogen: 9 785 $ op 31-08-2026

52 jaar
Health Technology
Consumer Services
Health Services

Profiel

Thomas Joseph Englese is Director at Therakos (UK) Ltd. since 2015.
Mr. Englese is Chief Commercial Officer at Tonix Pharmaceuticals Holding Corp.
starting in 2026.
Former roles include Senior Director-Business Operations at Baxter International, Inc. from 2002 to 2008, Vice President-Customer Operations at Ikaria, Inc. from 2008 to 2015, General Manager-North America Hospital Therapies at Keenova Therapeutics Plc from 2015 to 2019, and Chief Commercial Officer at Elutia, Inc. and Tris Pharma, Inc. Education includes an MBA from The Pennsylvania State University in 2002 and an undergraduate degree from Villanova University in 1996.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
04-09-2026 694 ( 0,01% ) 9 785 $ 31-08-2026

Actieve functies van Thomas Englese

BedrijvenFunctieBegin
TONIX PHARMACEUTICALS HOLDING CORP. Corporate Officer/Principal 10-09-2024
Directeur/Bestuurslid 30-10-2015

Eerdere bekende functies van Thomas Englese

BedrijvenFunctieEinde
MALLINCKRODT PLC Corporate Officer/Principal 01-07-2019
IKARIA, INC. Corporate Officer/Principal 01-03-2015
BAXTER INTERNATIONAL INC. Corporate Officer/Principal 01-01-2008
Corporate Officer/Principal -
ELUTIA INC. Corporate Officer/Principal -
Ervaring van Thomas Englese in detail bekijken

Opleiding van Thomas Englese

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

91

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

  1. Beurs
  2. Insiders
  3. Thomas Englese